低密度脂蛋白反应T细胞调节血胆固醇水平和动脉样硬化在人性化高胆固醇贫血小鼠
Anton Gisterå1, Maria L Klement1,2, Konstantinos A Polyzos1
1Department of Medicine, Center for Molecular Medicine, Karolinska University Hospital (A.G., M.L.K., K.A.P., R.K.W.M., D.F.J.K., G.K.H.), Karolinska Institutet, Stockholm, Sweden.
Circulation
|July 13, 2018
概括
通过增强LDL清除和减少炎症,对低密度脂蛋白 (LDL) 的免疫反应可以预防动脉样硬化. 这项研究阐明了LDL反应性T细胞如何促进这些有益的动脉保护作用.
科学领域:
- 免疫学
- 心血管生物学
- 代谢疾病
背景情况:
- 动脉样性心血管疾病包括由低密度脂蛋白 (LDL) 引起的慢性炎症.
- 识别LDL抗原的CD4+T细胞被招募到病变中,但由于LDL免疫研究的相互矛盾结果,它们的作用受到争议.
- 了解LDL反应性T细胞激活对于开发基于免疫的心血管疗法至关重要.
研究的目的:
- 研究LDL反应性T细胞激活对新陈代谢和血管病理的影响.
- 澄清T细胞在动脉样硬化中看似矛盾的作用.
主要方法:
- 开发一种T细胞受体转基因小鼠模型,用于研究对LDL的免疫反应.
- 使用采用细胞转移和与表达非脂蛋白B-100的高胆固醇小鼠进行杂交.
- 评估对动脉样硬化的发展和进展的影响.
主要成果:
- 一个对LDL反应的T细胞亚群分化为T毛囊辅助细胞,促进B细胞激活和抗LDLIgG抗体的产生.
- 抗LDL抗体通过免疫复合体的形成增强了LDL清除.
- 对LDL的免疫反应与便胆固醇分泌量的增加和血管炎症的减少有关.
结论:
- 抗LDL免疫活性触发了三种动脉保护机制:抗体介导的LDL清除,增加胆固醇分泌和减少血管炎症.
- 这些发现突出了动脉样硬化中特定免疫反应的保护作用.
- 针对LDL的免疫调节可能是心血管疾病的治疗策略.
相关概念视频
Cholesterol: Significance and Regulation
1.4K
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
1.4K
Master Transcription Regulators
7.8K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
7.8K
Atherosclerosis III: Management
433
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
433
pH Regulation in Cells
7.7K
pH plays a critical role in maintaining normal cellular activities. It helps maintain the structure and function of various proteins, dictates the charge on cellular membranes, and is crucial for metabolic reactions inside the cell. Moreover, cells use the energy from the proton motive force to generate ATP.
Cytosolic pH
Under physiological conditions, the cytosolic pH is slightly more acidic than the extracellular pH. However, cells must prevent further acidification of their cytosol to...
Cytosolic pH
Under physiological conditions, the cytosolic pH is slightly more acidic than the extracellular pH. However, cells must prevent further acidification of their cytosol to...
7.7K
Atherosclerosis I: Introduction
1.1K
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
1.1K
Factors Affecting Renal Clearance: Drug's Physicochemical Properties and Plasma Levels
604
Renal clearance of a drug is influenced by various factors, including its physicochemical properties and plasma levels. These factors play a significant role in determining how efficiently the kidneys eliminate a drug.
One important factor is the drug's molecular size. The kidneys readily excrete smaller molecules below 300 Daltons (Da). On the other hand, molecules weighing between 300 and 500 Da are excreted through both urine and bile. Larger molecules above 500 Da tend to be excreted...
One important factor is the drug's molecular size. The kidneys readily excrete smaller molecules below 300 Daltons (Da). On the other hand, molecules weighing between 300 and 500 Da are excreted through both urine and bile. Larger molecules above 500 Da tend to be excreted...
604


